| abstract |
A pharmaceutical pack is provided comprising as active ingredients (1) an antiviral agent active against hepatitis B virus and (2) a vaccine for the prophylaxis and/or treatment of hepatitis B infection. The active ingredients are for simultaneous or sequential use. Preferred components are a nucleotide/nucleoside analogue as the antiviral agent, together with a hepatitis B virus vaccine, which comprises a hepatitis B virus surface antigen. |